MedTrace Logo

Evaluation of Gluma Desensitizer in Post-treatment Sensitivity in Posterior Composite

NCT04248803 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 570

Last updated 2025-10-17

Study results available
· View outcomes & findings →

Summary

To evaluate the effect of Gluma desensitizer in controlling immediate post-treatment sensitivity in posterior occlusal composite restorations.

Conditions

  • Sensitivity, Tooth

Interventions

OTHER

GLUMA (Kulzer GmbH, Germany) desensitizing agent

GLUMA desensitizer is used to reduce tooth sensitivity

Sponsors & Collaborators

  • Tamil Nadu Dr.M.G.R.Medical University

    lead OTHER

Principal Investigators

  • GEETH DEEPIKA, MDS · TN MGR MEDICAL UNIVERSITY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-06
Primary Completion
2025-02-20
Completion
2025-02-20

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04248803 on ClinicalTrials.gov